| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Xiaoming Yang, Marpe Bam, Prakash S Nagarkatti, Mitzi Nagarkatt. RNA-seq Analysis of δ9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation. The Journal of biological chemistry. vol 291. issue 30. 2017-05-08. PMID:27268054. |
Δ9-tetrahydrocannabinol (thc), which is the main bioactive component in marijuana, has also been shown to possess potent anti-inflammatory properties by virtue of its ability to activate cannabinoid receptor-2 (cb-2) expressed on immune cells. |
2017-05-08 |
2023-08-13 |
mouse |
| Cinzia Citti, Giuseppe Ciccarella, Daniela Braghiroli, Carlo Parenti, Maria Angela Vandelli, Giuseppe Cannazz. Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method. Journal of pharmaceutical and biomedical analysis. vol 128. 2017-05-08. PMID:27268223. |
medicinal cannabis: principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method. |
2017-05-08 |
2023-08-13 |
Not clear |
| Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marz. From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology. Physiological reviews. vol 96. issue 4. 2017-05-04. PMID:27630175. |
apart from having been used and misused for at least four millennia for, among others, recreational and medicinal purposes, the cannabis plant and its most peculiar chemical components, the plant cannabinoids (phytocannabinoids), have the merit to have led humanity to discover one of the most intriguing and pleiotropic endogenous signaling systems, the endocannabinoid system (ecs). |
2017-05-04 |
2023-08-13 |
human |
| Ola Røed Bilgre. From "herbal highs" to the "heroin of cannabis": Exploring the evolving discourse on synthetic cannabinoid use in a Norwegian Internet drug forum. The International journal on drug policy. vol 29. 2017-05-02. PMID:26860324. |
from "herbal highs" to the "heroin of cannabis": exploring the evolving discourse on synthetic cannabinoid use in a norwegian internet drug forum. |
2017-05-02 |
2023-08-13 |
Not clear |
| Joseph Ta. The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases. Journal of basic and clinical physiology and pharmacology. vol 27. issue 3. 2017-04-20. PMID:26280171. |
endocannabinoids (ecbs) are endogenous lipid ligands that bind to cannabinoid receptors that also mediate the effects of marijuana. |
2017-04-20 |
2023-08-13 |
mouse |
| Raphael Mechoula. Cannabis - the Israeli perspective. Journal of basic and clinical physiology and pharmacology. vol 27. issue 3. 2017-04-20. PMID:26426888. |
short overviews are presented on the historical uses of cannabis in the middle east and on the more recent scientific and medical research on phytocannabinoids and the endocannabinoid system, with emphasis on research contributions from israel. |
2017-04-20 |
2023-08-13 |
Not clear |
| Raphael Mechoula. Cannabis - the Israeli perspective. Journal of basic and clinical physiology and pharmacology. vol 27. issue 3. 2017-04-20. PMID:26426888. |
these are followed by examples of research projects and clinical trials with cannabinoids and by a short report on the regulation of medical marijuana in israel, which at present is administered to over 22,000 patients. |
2017-04-20 |
2023-08-13 |
Not clear |
| M-A Fitzcharles, C Baerwald, J Ablin, W Häuse. Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials. Schmerz (Berlin, Germany). vol 30. issue 1. 2017-04-20. PMID:26767993. |
in the absence of an ideal treatment for chronic pain associated with rheumatic diseases, there is interest in the potential effects of cannabinoid molecules, particularly in the context of global interest in the legalization of herbal cannabis for medicinal use. |
2017-04-20 |
2023-08-13 |
Not clear |
| Andreas Zimme. A collaboration investigating endocannabinoid signalling in brain and bone. Journal of basic and clinical physiology and pharmacology. vol 27. issue 3. 2017-04-20. PMID:26887036. |
investigations into the cellular and molecular mechanisms underlying the psychoactive effects of cannabis preparations have led to the discovery of the endocannabinoid system. |
2017-04-20 |
2023-08-13 |
Not clear |
| Johanna Bjurström, Steffen Frii. [Cyclic vomiting and abdominal pain from prolonged cannabis use]. Lakartidningen. vol 113. 2017-04-17. PMID:27219080. |
cannabinoid hyperemesis syndrome (chs) was suspected and the patient admitted having used cannabis daily for the past seven years. |
2017-04-17 |
2023-08-13 |
Not clear |
| Wen-Juan Huang, Wei-Wei Chen, Xia Zhan. Endocannabinoid system: Role in depression, reward and pain control (Review). Molecular medicine reports. vol 14. issue 4. 2017-04-05. PMID:27484193. |
in ancient times, this depression-pain comorbidity was treated using extracts of the cannabis sativa plant, known now as marijuana and the mode of action of Δ9‑tetrahydrocannabinol, the active cannabinoid ingredient of marijuana, has only recently become known, with the identification of cannabinoid receptor type 1 (cb1) and cb2. |
2017-04-05 |
2023-08-13 |
Not clear |
| Damon Borg, Anna Tverdovsky, Richard Strip. A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS. Journal of analytical toxicology. vol 41. issue 1. 2017-03-31. PMID:27681343. |
synthetic cannabinoids are a group of psychoactive compounds that mimic the effects of Δ9-tetrahydrocannabinol, the primary psychoactive constituent of marijuana (cannabis sativa l). |
2017-03-31 |
2023-08-13 |
Not clear |
| Astrid Vinsand Naver, Klaus Theed. [Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse]. Ugeskrift for laeger. vol 177. issue 18. 2017-03-29. PMID:25922240. |
[cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse]. |
2017-03-29 |
2023-08-13 |
Not clear |
| Astrid Vinsand Naver, Klaus Theed. [Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse]. Ugeskrift for laeger. vol 177. issue 18. 2017-03-29. PMID:25922240. |
the link between repeated episodes of nausea, vomiting, and cannabis abuse is often missed in patients with prolonged cannabis abuse and is named cannabinoid hyperemesis syndrome. |
2017-03-29 |
2023-08-13 |
Not clear |
| Mauro Maccarrone, Rafael Maldonado, Miguel Casas, Thomas Henze, Diego Centonz. Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? Expert review of clinical pharmacology. vol 10. issue 4. 2017-03-29. PMID:28276775. |
in this regard it should be remembered that herbal cannabis contains a myriad of active ingredients, and the individual cannabinoids have quite distinct biological activities requiring independent studies. |
2017-03-29 |
2023-08-13 |
human |
| Michele Protti, James Rudge, Angelo Eliseo Sberna, Gilberto Gerra, Laura Mercolin. Dried haematic microsamples and LC-MS/MS for the analysis of natural and synthetic cannabinoids. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. vol 1044-1045. 2017-03-24. PMID:28088044. |
synthetic cannabinoids are new psychoactive substances (nps) with similar effects when compared to natural ones found in cannabis derivatives. |
2017-03-24 |
2023-08-13 |
Not clear |
| Erin L Karschner, Madeleine J Swortwood, Jussi Hirvonen, Robert S Goodwin, Wendy M Bosker, Johannes G Ramaekers, Marilyn A Huesti. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance. Drug testing and analysis. vol 8. issue 7. 2017-03-15. PMID:26097154. |
extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance. |
2017-03-15 |
2023-08-13 |
human |
| Erin L Karschner, Madeleine J Swortwood, Jussi Hirvonen, Robert S Goodwin, Wendy M Bosker, Johannes G Ramaekers, Marilyn A Huesti. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance. Drug testing and analysis. vol 8. issue 7. 2017-03-15. PMID:26097154. |
our aims were to establish plasma cannabinoid detection windows in frequent cannabis smokers and to determine if residual cannabinoid concentrations were correlated with psychomotor performance. |
2017-03-15 |
2023-08-13 |
human |
| Rebecca L Hartman, Timothy L Brown, Gary Milavetz, Andrew Spurgin, David A Gorelick, Gary Gaffney, Marilyn A Huesti. Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships. Drug testing and analysis. vol 8. issue 7. 2017-03-15. PMID:26257143. |
controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships. |
2017-03-15 |
2023-08-13 |
human |
| Rebecca L Hartman, Timothy L Brown, Gary Milavetz, Andrew Spurgin, David A Gorelick, Gary Gaffney, Marilyn A Huesti. Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships. Drug testing and analysis. vol 8. issue 7. 2017-03-15. PMID:26257143. |
we evaluated the subjective effects of cannabis, with and without alcohol, relative to blood and oral fluid (of, advantageous for cannabis exposure screening) cannabinoid concentrations and of/blood and of/plasma vaporized-cannabinoid relationships. |
2017-03-15 |
2023-08-13 |
human |